Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Torrent Pharmaceuticals's Days Inventory or its related term are showing as below:
NSE:TORNTPHARM'
s Days Inventory Range Over the Past 10 Years
Min: 281.89 Med: 305.83 Max: 394.3
Current: 292.55
During the past 13 years, Torrent Pharmaceuticals's highest Days Inventory was 394.30. The lowest was 281.89. And the median was 305.83.
NSE:TORNTPHARM's Days Inventory is ranked worse than 82.99% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs NSE:TORNTPHARM: 292.55
Torrent Pharmaceuticals's Days Inventory
declined
from Mar. 2025 (317.22) to Mar. 2026 (282.13).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Torrent Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Torrent Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.76.
Torrent Pharmaceuticals (NSE:TORNTPHARM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Torrent Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Torrent Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Torrent Pharmaceuticals Days Inventory Related Terms
Torrent Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:TORNTPHARM vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Torrent Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Torrent Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Torrent Pharmaceuticals (NSE:TORNTPHARM) has a Days Inventory of 282.13 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Torrent Pharmaceuticals and its competitors. This is near median its historical median of 305.83. Over the past decade, Torrent Pharmaceuticals' Days Inventory has ranged from 281.89 to 394.30. According to the industry distribution chart, Torrent Pharmaceuticals ranks #766 out of 923 companies in the Drug Manufacturers industry, placing it in the top 83%.
Is Torrent Pharmaceuticals' Days Inventory too high?
Torrent Pharmaceuticals' current Days Inventory of 282.13 is near median its 10-year median of 305.83. Over the past 10 years, this metric has ranged from a low of 281.89 to a high of 394.30. The Drug Manufacturers industry median Days Inventory is 164.38. Torrent Pharmaceuticals' value of 282.13 is 71.6% above this industry median. Based on the distribution chart, Torrent Pharmaceuticals ranks #766 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Torrent Pharmaceuticals has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Torrent Pharmaceuticals' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Torrent Pharmaceuticals ranks #766 out of 923 companies for Days Inventory. This places Torrent Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 164.38. Torrent Pharmaceuticals' value of 282.13 is 71.6% above this benchmark. Historically, Torrent Pharmaceuticals' own Days Inventory has ranged from 281.89 to 394.30 over the past decade. While the company's 10-year median is 305.83 vs. the industry median of 164.38, Torrent Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Torrent Pharmaceuticals's current Days Inventory of 282.13 is 71.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Torrent Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Torrent Pharmaceuticals's current Days Inventory is 282.13, which is near median its own 10-year median of 305.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Torrent Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Torrent Pharmaceuticals (NSE:TORNTPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹4,388.87, compared to a current price of ₹4,763.00 — trading 8.5% above its estimated fair value. The current Days Inventory is 282.13, which is near median its 10-year median of 305.83 and 71.6% above the Drug Manufacturers industry median of 164.38. Torrent Pharmaceuticals' overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Torrent Pharmaceuticals (NSE:TORNTPHARM), the current Days Inventory is 282.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Overvalued in 2026?
Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹4,763.00 is trading 8.5% above its estimated GF Value™ of ₹4,388.87.
GuruFocus considers Torrent Pharmaceuticals to be Fairly Valued.
Key valuation signals for NSE:TORNTPHARM:
Days Inventory: 282.13 (near median its 10-year median of 305.83)
GF Value™: ₹4,388.87 vs. price of ₹4,763.00 (8.5% above fair value)
Industry Position: 71.6% above the Drug Manufacturers median (#766 of 923)
No single metric tells the full story. See the NSE:TORNTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
86GF Score
Get the complete analysis for NSE:TORNTPHARM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TORNTPHARM has been successfully added to your 
